NCT07371650Phase 2Active not recruiting

This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenza

Study sponsor: Traws Pharma, Inc. · TRAW

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2026-12Estimated

Enrollment · participants105Estimated

Source updated2026-03-27Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-02-06 · 4 fields changed

Participant count type changed

− Before

~~Actual~~

+ After

Estimated

Enrollment · participant count changed

− Before

~~0 participants (actual)~~

+ After

105 participants (planned)

Primary completion date changed

− Before

~~Jun 2026~~

+ After

Dec 2026

Recruitment status changed

− Before

~~Withdrawn~~

+ After

Active not recruiting

Check registry source

Study details

Conditions studied

Influenza

Treatments or interventions studied

TRX-100Drug
Standard of Care (SOC)Drug

Primary outcomes · main study measures

Read the study measures

measure: Incidence of AE/SAE; description: Number of participants with Adverse Events (AEs), serious Adverse Events (SAEs) (including withdrawals due to AEs); timeFrame: up to Day 28; measure: Incidence of abnormal laboratory tests results; description: Number of participants with abnormal laboratory tests results; timeFrame: Up to Day 28; measure: Incidence of abnormal clinically significant ECG results; timeFrame: Up to 28 days; measure: Number of participants with abnormal physical examinations findings; timeFrame: Up to 28 days

History coverage

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

How to read this history